M. Airik Et Al. , "Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion," FASEB JOURNAL , vol.36, no.2, 2022
Airik, M. Et Al. 2022. Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion. FASEB JOURNAL , vol.36, no.2 .
Airik, M., McCourt, B., TAŞTEMEL ÖZTÜRK, T., Huynh, A. B., Zhang, X., Tometich, J. T., ... TOPALOĞLU, R.(2022). Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion. FASEB JOURNAL , vol.36, no.2.
Airik, Merlin Et Al. "Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion," FASEB JOURNAL , vol.36, no.2, 2022
Airik, Merlin Et Al. "Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion." FASEB JOURNAL , vol.36, no.2, 2022
Airik, M. Et Al. (2022) . "Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion." FASEB JOURNAL , vol.36, no.2.
@article{article, author={Merlin Airik Et Al. }, title={Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion}, journal={FASEB JOURNAL}, year=2022}